Vigilare Wealth Management’s Medtronic MDT Stock Holding History

Vigilare Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,925	Closed	-$263K	–	115
2022 Q2	$263K	Buy	+2,925	New	+$296K	0.29%	85

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vigilare Wealth Management's MDT Position: Q3 2022 in Review

Vigilare Wealth Management sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,925 shares — an estimated $263K sold.

Vigilare Wealth Management first reported a position in MDT in Q2 2022 and held it in 1 quarter. The position peaked at $263K in Q2 2022. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

Vigilare Wealth Management reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
Vigilare Wealth Management sold 2,925 Medtronic shares in Q3 2022, an estimated $263K.
Vigilare Wealth Management first reported a position in Medtronic in Q2 2022 and held it in 1 quarter.
Vigilare Wealth Management's Medtronic position peaked at $263K in Q2 2022.
1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Vigilare Wealth Management's 13F filing for Q3 2022, filed 20 Oct 2022.